163 related articles for article (PubMed ID: 22436293)
1. Azelnidipine, unique calcium channel blocker could prevent stress-induced cardiac dysfunction like α·β blocker.
Takano Y; Ueyama T; Ishikura F
J Cardiol; 2012 Jul; 60(1):18-22. PubMed ID: 22436293
[TBL] [Abstract][Full Text] [Related]
2. Acute effects of beta-blocker with intrinsic sympathomimetic activity on stress-induced cardiac dysfunction in rats.
Ishikura F; Takano Y; Ueyama T
J Cardiol; 2012 Dec; 60(6):470-4. PubMed ID: 22898333
[TBL] [Abstract][Full Text] [Related]
3. Amlodipine has a preventive effect on temporal left ventricular hypokinesia after emotional stress compared with an angiotensin II receptor blocker.
Ishikura F; Takano Y; Ueyama T
J Med Ultrason (2001); 2013 Jan; 40(1):3-7. PubMed ID: 27276918
[TBL] [Abstract][Full Text] [Related]
4. Hemodynamic influences of azelnidipine, a novel calcium channel blocker, on cerebral circulation in hypertensive patients with ischemic white matter lesions.
Kimura Y; Kitagawa K; Oku N; Kajimoto K; Kato H; Tanaka M; Sakaguchi M; Hougaku H; Sakoda S; Hatazawa J
Hypertens Res; 2008 Dec; 31(12):2147-54. PubMed ID: 19139604
[TBL] [Abstract][Full Text] [Related]
5. Azelnidipine attenuates cardiovascular and sympathetic responses to air-jet stress in genetically hypertensive rats.
Nakamoto M; Ohya Y; Sakima A; Yamazato M; Takishita S
Hypertens Res; 2007 Apr; 30(4):359-66. PubMed ID: 17541215
[TBL] [Abstract][Full Text] [Related]
6. Azelnidipine decreases sympathetic nerve activity via antioxidant effect in the rostral ventrolateral medulla of stroke-prone spontaneously hypertensive rats.
Konno S; Hirooka Y; Araki S; Koga Y; Kishi T; Sunagawa K
J Cardiovasc Pharmacol; 2008 Dec; 52(6):555-60. PubMed ID: 19057394
[TBL] [Abstract][Full Text] [Related]
7. Effects of a new calcium channel blocker, azelnidipine, on systemic hemodynamics and renal sympathetic nerve activity in spontaneously hypertensive rats.
Shokoji T; Fujisawa Y; Kiyomoto H; Rahman M; Sun GP; Fan YY; Kimura S; Kohno M; Abe Y; Nishiyama A
Hypertens Res; 2005 Dec; 28(12):1017-23. PubMed ID: 16671342
[TBL] [Abstract][Full Text] [Related]
8. Long-acting calcium channel blocker, azelnidipine, increases endothelial nitric oxide synthase in the brain and inhibits sympathetic nerve activity.
Kimura Y; Hirooka Y; Sagara Y; Sunagawa K
Clin Exp Hypertens; 2007 Jan; 29(1):13-21. PubMed ID: 17190727
[TBL] [Abstract][Full Text] [Related]
9. Azelnidipine attenuates glomerular damage in Dahl salt-sensitive rats by suppressing sympathetic nerve activity.
Nagasu H; Satoh M; Fujimoto S; Tomita N; Sasaki T; Kashihara N
Hypertens Res; 2012 Mar; 35(3):348-55. PubMed ID: 22072106
[TBL] [Abstract][Full Text] [Related]
10. Effects of new calcium channel blocker, azelnidipine, and amlodipine on baroreflex sensitivity and ambulatory blood pressure.
Eguchi K; Tomizawa H; Ishikawa J; Hoshide S; Fukuda T; Numao T; Shimada K; Kario K
J Cardiovasc Pharmacol; 2007 Jun; 49(6):394-400. PubMed ID: 17577104
[TBL] [Abstract][Full Text] [Related]
11. Chronotropic effects of azelnidipine, a slow- and long-acting dihydropyridine-type calcium channel blocker, in anesthetized dogs: a comparison with amlodipine.
Fujisawa M; Yorikane R; Chiba S; Koike H
J Cardiovasc Pharmacol; 2009 Apr; 53(4):325-32. PubMed ID: 19295444
[TBL] [Abstract][Full Text] [Related]
12. The pharmacological differences in antianginal effects of long-lasting calcium channel blockers: azelnidipine and amlodipine.
Fujisawa M; Yorikane R; Matsuoka Y; Koike H; Ueno K
J Cardiovasc Pharmacol; 2013 Jan; 61(1):63-9. PubMed ID: 23288106
[TBL] [Abstract][Full Text] [Related]
13. Prevention of neuronal damage by calcium channel blockers with antioxidative effects after transient focal ischemia in rats.
Lukic-Panin V; Kamiya T; Zhang H; Hayashi T; Tsuchiya A; Sehara Y; Deguchi K; Yamashita T; Abe K
Brain Res; 2007 Oct; 1176():143-50. PubMed ID: 17904110
[TBL] [Abstract][Full Text] [Related]
14. The calcium-channel blocker, azelnidipine, enhances the inhibitory action of AT1 receptor blockade on ischemic brain damage.
Iwai M; Chen R; Ide A; Iwanami J; Tomochika H; Tomono Y; Mogi M; Horiuchi M
J Hypertens; 2006 Oct; 24(10):2023-31. PubMed ID: 16957563
[TBL] [Abstract][Full Text] [Related]
15. [Pharmacological profiles and clinical effects of azelnidipine, a long-acting calcium channel blocker].
Sada T; Saito H
Nihon Yakurigaku Zasshi; 2003 Dec; 122(6):539-47. PubMed ID: 14639008
[TBL] [Abstract][Full Text] [Related]
16. Azelnidipine exerts renoprotective effects by improvement of renal microcirculation in angiotensin II infusion rats.
Fujimoto S; Satoh M; Nagasu H; Horike H; Sasaki T; Kashihara N
Nephrol Dial Transplant; 2009 Dec; 24(12):3651-8. PubMed ID: 19666664
[TBL] [Abstract][Full Text] [Related]
17. Calcium channel blocker azelnidipine enhances vascular protective effects of AT1 receptor blocker olmesartan.
Jinno T; Iwai M; Li Z; Li JM; Liu HW; Cui TX; Rakugi H; Ogihara T; Horiuchi M
Hypertension; 2004 Feb; 43(2):263-9. PubMed ID: 14707152
[TBL] [Abstract][Full Text] [Related]
18. Azelnidipine reduces urinary protein excretion and urinary liver-type fatty acid binding protein in patients with hypertensive chronic kidney disease.
Nakamura T; Sugaya T; Kawagoe Y; Suzuki T; Ueda Y; Koide H; Inoue T; Node K
Am J Med Sci; 2007 Jun; 333(6):321-6. PubMed ID: 17570983
[TBL] [Abstract][Full Text] [Related]
19. Impact of azelnidipine treatment on left ventricular diastolic performance in patients with hypertension and mild diastolic dysfunction: multi-center study with echocardiography.
Ito H; Ishii K; Iwakura K; Nakamura F; Nagano T; Takiuchi S
Hypertens Res; 2009 Oct; 32(10):895-900. PubMed ID: 19680260
[TBL] [Abstract][Full Text] [Related]
20. Azelnidipine is a useful medication for the treatment of heart failure preserved ejection fraction.
Kiuchi S; Hisatake S; Kabuki T; Oka T; Dobashi S; Fujii T; Ikeda T
Clin Exp Hypertens; 2017; 39(4):350-354. PubMed ID: 28513286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]